Egg-allergic patients gain greater access to H1N1 vaccine after completion of clinical trial.
Eggertson
Laura
L
D000707:Anaphylaxis / Q000453:epidemiology / Q000517:prevention & control; D002170:Canada / Q000453:epidemiology; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D021181:Egg Hypersensitivity / Q000453:epidemiology*; D006297:Health Services Accessibility; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000276:immunology; D017410:Practice Guidelines as Topic
D007252:Influenza Vaccines